Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Pravastatin in pediatric ADPKD
NCT00456365Phase 3Completed
- Sponsor
- University of Colorado Denver
- Start
- Nov 2006
- Primary completion
- Oct 2012
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 3, randomised, double-blind trial in autosomal dominant polycystic kidney disease (ADPKD) comparing Pravastatin with Placebo (2 arms). Primary endpoint: Percent of Participants Demonstrating 20% or More Increase in Total Kidney Volume at 3 years. Started Nov 2006; status: completed.
02
Drugs
pravastatin
03
Conditions
autosomal dominant polycystic kidney disease (ADPKD)
Beyond the preview
Go deeper on NCT00456365.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00456365.